jessica flechtner  mass high tech  zoominfocom jessica baker flechtner  genocea biosciences inc  email vice president of research  genoceacom  phone     business card for jessica baker flechtner jessica baker flechtner vice president of research cambridge ma areaemail avail  day free trial genocea biosciences inc  acorn park th floor cambridge ma  tel   wwwgenoceacom last updated on    get contact info  its free and takes  seconds opt out or update this contact opt out update name update title update phone update email not at this company anymore about jessica baker flechtner jessica baker flechtner works as an vice president of research for genocea biosciences inc at cambridge ma the companys webpage is httpwwwgenoceacom for email phone number and executive profiles for vice president of research and other executives of genocea biosciences inc at cambridge ma check genocea biosciences inc at joesdatacom not the jessica baker flechtner you are looking for do a quick search in our website and find other people named jessica baker flechtner jessica baker flechtners work history no information available jessica baker flechtners education no information available jessica baker flechtners coworkers as of july   jessica baker flechtner has  coworkers under the company name genocea biosciences inc at joesdatacom about genocea biosciences inc genocea biosciences inc is located at  acorn park th floor  cambridge ma  it has around    employees its revenue is under m genocea biosciences inc is a biopharmaceutical company the company discovers and develops vaccines and immunotherapies it uses its discovery platform antigen lead acquisition system atlas to design vaccines and immunotherapies that act in part through t cell or cellular immune responses the company operates through business of developing and commercializing vaccines segment it has one product candidate in phase ii clinical development gen which is a therapeutic vaccine or immunotherapy for the treatment of genital herpes infections it has preclinical development programs which include gen which is indicated for the treatment of chlamydia prophylaxis and gen which indicated for the treatment of genital herpes prophylaxis both of which are in preclinical stage of development the companys pipeline also includes gen which is under malaria prophylaxis epsteinbarr virus and immunooncology programs in research stage of development company news no company news available people in the same industry david shoemakersenior vice president research and developmentrho incning huangvice president of research and developmentinvitriajeff hrkachsenior vice president research and developmentbind biosciences incdave byronvice presidentresearch and developmentmicrodose therapeutx incmatthew seefeldtvice president researchbarofold incjessica baker flechtnervice president of researchgenocea biosciences inc about us privacy terms of use work for us contact us people directory a b c d e f g h i j k l m n o p q r s t u v w x y z company directory a b c d e f g h i j k l m n o p q r s t u v w x y z copyright   joesdatacom all rights reserved gnca jessica baker flechtner insider trades for genocea biosciences inc bulletin investor alert new york markets after hours market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close genocea biosciences inc nasdaq gnca go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus genocea biosciences inc after hours  quotes are delayed by  min jul    pm gnca quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   insider activity individual jessica baker flechtner dr jessica b flechtner is chief scientific officer at genocea biosciences inc a member at american association for cancer research a member at american society for microbiology and a member at the american association of immunologists dr flechtner was previously employed as a consultant by biovest international inc and a principal by mojave therapeutics inc she received his undergraduate degree from cornell university and a doctorate degree from cornell university transactions date shares transaction value     derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr william d clark president chief executive officer  director mr jonathan michael poole chief financial officer  headinvestor relations dr seth v hetherington chief medical officer dr jessica baker flechtner chief scientific officer dr john e bishop senior vice presidentpharmaceutical sciences dr eric s hoffman chief business officer dr howard mayer director dr george r siber executive director ms katrine s bosley chairman mr ronald cooper independent director mr michael j higgins independent director mr kenneth m bate independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical p‘game of thrones’ the four biggest takeaways from stormborn’ pamazon’s stock drop after results is the smallest in seven years prussell’s ‘line in the sand’ against snap could give investors more control p‘game of thrones’ science let’s take a closer look at that greyscale pdow jones industrial average advances more than  this week pcomcast is trying to win over millennials with new streaming service pwall street isn’t ready for a point tumble in the dow industrials pstocks end muddled for the week on mixed batch of secondquarter earnings p‘atomic blonde’ shows — again — kickass roles for women are good for hollywood loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  genocea congratulates jessica baker flechtner phd for recognition on s  women to watch over  list  pg  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street genocea congratulates jessica baker flechtner phd for recognition on s  women to watch over  list globenewswire aug    am edt about genocea biosciences inc genocea is harnessing the power of t cell immunity to develop lifechanging vaccines and immunotherapies t cells are increasingly recognized as a critical element of protective immune responses to a wide range of diseases but traditional discovery methods have proven unable to identify the targets of such protective immunity using atlas its proprietary technology platform genocea identifies these targets to potentially enable the rapid development of medicines to address critical patient needs genoceas pipeline of novel clinical stage t cellenabled product candidates includes gen for genital herpes gen for the prevention of infection by all serotypes of pneumococcus development suspended and earlierstage programs in chlamydia genital herpes prophylaxis malaria and cancer immunotherapy for more information please visit the companys website at wwwgenoceacom for media liz bryan spectrum science communications inco  lbryanspectrumsciencecom for investors jonathan poolegenocea biosciences inco  jonathanpoolegenoceacom if you liked this article you might like  swing for the fences small biotechs genocea biosciences and eiger biopharmaceuticals are high riskhigh reward plays bret jensen apr    pm edt  swing for the fences small biotechs genocea biosciences and eiger biopharmaceuticals are high riskhigh reward plays bret jensen apr    pm edt vegas baby rolling s in biotech three smallcap biotechs with attractive riskreward profiles bret jensen apr    am edt this tradingrange action is not offering much if you want to trade you have to maintain short timeframes and be ready to flip rev shark apr    am edt advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers genocea congratulates jessica baker flechtner phd for recognition on s  women to watch over  list  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street genocea congratulates jessica baker flechtner phd for recognition on s  women to watch over  list globenewswire aug    am edt cambridge mass aug   globe newswire  genocea biosciences inc nasdaqgnca a biopharmaceutical company developing t celldirected vaccines and immunotherapies is delighted to congratulate jessica baker flechtner phd chief scientific officer who was acknowledged as an honoree on this years  women to watch over  list the list founded in  celebrates the achievements of women over  who are pushing boundaries in their respective industries the  over  list highlights an inspiring lineup of women who are reinventing disrupting and making an impact in their fields in her role as chief scientific officer dr flechtner leads a team of scientists and researchers focused on innovation in t cell target discovery and vaccine development for infectious diseases and cancers dr flechtner has been instrumental in expanding the companys focus into oncology establishing important collaborations with leading academic centers to advance the understanding of t cell immune responses to cancers and inform genoceas cancer vaccine development strategy this is a welldeserved honor and distinction and i am delighted to have had the privilege of working closely with jessica over the past several years her many successes are an inspiration to those around her said chip clark president and chief executive officer of genocea in addition to being an accomplished scientist strategist and exemplary leader at genocea jessica serves as a mentor and positive role model for young women interested in pursuing stem careers helping to build the next generation of biotech leaders winners were selected based on a rigorous application and judging process that evaluated three areas impact role model and reinvention and momentum to view the complete list of  winners click here httpfortyovercomhonorees   if you liked this article you might like  swing for the fences small biotechs genocea biosciences and eiger biopharmaceuticals are high riskhigh reward plays bret jensen apr    pm edt  swing for the fences small biotechs genocea biosciences and eiger biopharmaceuticals are high riskhigh reward plays bret jensen apr    pm edt vegas baby rolling s in biotech three smallcap biotechs with attractive riskreward profiles bret jensen apr    am edt this tradingrange action is not offering much if you want to trade you have to maintain short timeframes and be ready to flip rev shark apr    am edt trending starbucks shares are plunging by more than   go out and buy amazon shares could still bust open your wallet if you arent very careful donald trump can now blame apple for atlantics reporting worst performing tech stocks amzn amd mu wdc us steel shares are being torched thanks to one stock analyst advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers dr jessica baker flechtner  manufacturing  dr jessica baker flechtner  chief scientific officer genocea biosciences inc jessica baker flechtner phd joined genocea biosciences in  soon after the company was founded and currently serves as the senior vice president of research dr flechtner is a pioneer in the development of novel vaccines directed toward t cell immunity and has more than  years of experience in immunology infectious disease cancer and vaccine development  she leads genocea’s efforts to develop t celldirected vaccines and immunotherapies against infectious diseases and cancer prior to joining genocea dr flechtner developed vaccines and immunotherapies for cancer infectious disease autoimmunity and allergy in several companies including mojave therapeutics and antigenics inc now agenus she is an inventor on multiple issued and pending patents dr flechtner performed her postdoctoral work at the dana farber cancer institute and harvard medical school she holds a phd in cellular immunology and a bs in animal science from cornell university and is a member of the american association of immunologists and american society for microbiology back to speakers event technology partner organiser jessica baker flechtner  genocea biosciences insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsjessica baker flechtnergenocea biosciences gncavp of research not rankedjessica baker flechtners performancejessica baker flechtner has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked insider holdings  genocea biosciences gncaksee the top stocks by insiders  insider rolesgenocea biosciences gnca vp of researchsee the top  corporate insiders  most profitable insider tradestock genocea biosciences gncatransaction type informative buydates dec    dec  gain see the latest stocks traded by insiders  jessica baker flechtners trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction dategncagenocea biosciencesvp of researchinformative buydec  success rate on stock out of  profitable transactions on gncaaverage profit on stockaverage return per transaction on gnca  track record showingall transactionsinformative transactionsdatetransactionamountno of sharesprice per shareprofitform  dec   informative buy k    sep   uninformative sell k   na aug   uninformative sell k   na show moresee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by